Journal
NANOMEDICINE
Volume 12, Issue 8, Pages 819-823Publisher
FUTURE MEDICINE LTD
DOI: 10.2217/nnm-2017-0039
Keywords
characterization; clinical challenges; commercialization; manufacturing scale-up; nanomedicine; nanopharmaceuticals; regulatory challenges; reproducibility
Ask authors/readers for more resources
The successful clinical translation of nanomedicine has challenges of reproducible manufacturing and scale-up, lack of acceptable screening platforms and reliable techniques to evaluate the efficacy, toxicity and stability in vivo.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
